Related Experiment Videos
Immunoglobulin mRNA stability varies during B lymphocyte differentiation.
1Laboratory of Radiobiology and Environmental Health, University of California, San Francisco 94143-0750.
The EMBO Journal
|April 1, 1988
Summary
During B lymphocyte differentiation, changes in immunoglobulin heavy chain production are linked to messenger RNA (mRNA) levels. This study reveals mRNA stability, not transcription, drives these changes in B cells.
Area of Science:
- Immunology
- Molecular Biology
- Cell Differentiation
Background:
- B lymphocyte differentiation involves significant changes in immunoglobulin heavy chain production.
- Steady-state levels of heavy chain mRNA reflect the amount of immunoglobulin produced.
- Previous understanding suggested transcription rates might vary during B cell differentiation.
Purpose of the Study:
- To investigate the regulatory mechanisms controlling immunoglobulin heavy chain mRNA levels during B cell differentiation.
- To determine whether changes in mRNA transcription or stability account for varying mRNA levels.
- To clarify the role of mRNA stability in B cell maturation to plasma cells.
Main Methods:
- Analysis of immunoglobulin mu heavy chain gene transcription rates at different B cell differentiation stages.
- Measurement of mu heavy chain mRNA stability during differentiation from pre-B cells to plasma cells.
- Comparison of transcription rates and mRNA stability to steady-state mRNA levels.
Main Results:
- Transcription rates of the immunoglobulin mu heavy chain gene remain constant during B cell differentiation.
- Significant differences in mu mRNA stability were observed between pre-B cells, small B cells, and plasma cells.
- mRNA stability directly correlates with the observed differences in steady-state heavy chain mRNA levels.
Conclusions:
- Post-transcriptional regulation, specifically mRNA stability, is the primary determinant of immunoglobulin heavy chain mRNA levels during B cell differentiation.
- Differences in mRNA stability are sufficient to explain the low mRNA levels in pre-B and small B cells and the high levels in plasma cells.
- This finding highlights mRNA stability as a key regulatory point in achieving high-level antibody production in plasma cells.